HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 243 filers reported holding HORIZON PHARMA PLC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,048,000 | -3.5% | 153,152 | -28.7% | 0.00% | 0.0% |
Q4 2018 | $4,195,000 | +52.3% | 214,701 | +52.6% | 0.00% | +100.0% |
Q3 2018 | $2,755,000 | +80.8% | 140,688 | +52.8% | 0.00% | +100.0% |
Q2 2018 | $1,524,000 | -68.3% | 92,073 | -72.8% | 0.00% | -75.0% |
Q1 2018 | $4,815,000 | -46.3% | 339,101 | -44.8% | 0.00% | -42.9% |
Q4 2017 | $8,962,000 | -50.0% | 613,831 | -56.6% | 0.01% | -50.0% |
Q3 2017 | $17,929,000 | -42.9% | 1,413,934 | -46.5% | 0.01% | -50.0% |
Q2 2017 | $31,396,000 | +963.9% | 2,644,951 | +1224.2% | 0.03% | +1300.0% |
Q1 2017 | $2,951,000 | -52.3% | 199,733 | -47.8% | 0.00% | -60.0% |
Q4 2016 | $6,187,000 | +64.4% | 382,354 | +84.2% | 0.01% | +66.7% |
Q3 2016 | $3,763,000 | +65.9% | 207,581 | +50.8% | 0.00% | +50.0% |
Q2 2016 | $2,268,000 | -14.7% | 137,632 | -14.2% | 0.00% | -33.3% |
Q1 2016 | $2,660,000 | -45.5% | 160,494 | -28.8% | 0.00% | -40.0% |
Q4 2015 | $4,884,000 | +70.6% | 225,449 | +56.1% | 0.01% | +66.7% |
Q3 2015 | $2,862,000 | -1.9% | 144,399 | +72.0% | 0.00% | +50.0% |
Q2 2015 | $2,916,000 | +128.9% | 83,930 | +71.2% | 0.00% | +100.0% |
Q1 2015 | $1,274,000 | +373.6% | 49,034 | +135.0% | 0.00% | – |
Q4 2014 | $269,000 | +258.7% | 20,865 | +245.1% | 0.00% | – |
Q3 2014 | $75,000 | – | 6,046 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FNY Investment Advisers, LLC | 144,340 | $16,698 | 9.92% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 45,559 | $3,145 | 0.01% |